Adding more compounds increases the complexity and introduces potential risks: Additive side effects : Researchers must account for the possibility of combined side effects, such as injection site reactions, headaches, or gastrointestinal discomfort, which have been observed with individual peptides
Clinically, qualifying for GLP-1 therapy typically requires meeting one of two conditions: a BMI of 30 kg/m or greater, or a BMI of 27 kg/m or greater combined with an obesity-related comorbidity such as type 2 diabetes or cardiovascular risk factors
It is kind of a buyer-beware market, said Campbell
Following the guidelines isn't just about playing it safe
Braidy et al
Its structure allows researchers to focus on specific pathway behavior, receptor interaction, and cellular responses under controlled experimental conditions